Iodine catalyzed synthesis of imidazo[1,2-]pyrazine and imidazo[1,2-]pyridine derivatives and their anticancer activity

An efficient iodine-catalyzed method for synthesizing imidazo[1,2- a ]pyrazines and imidazo[1,2- a ]pyridines via one-pot three-component condensations has been reported. The product, generated in situ by the reaction between an aryl aldehyde and 2-aminopyridine or 2-aminopyrazine, undergoes [4 + 1] cycloaddition with tert -butyl isocyanide, affording the corresponding imidazopyrazine and imidazopyridine derivatives in good yields. The photophysical properties of these new fluorescent derivatives are also presented. The anti-cancer activities of the synthesized compounds ( 10a-m ) and ( 12a-l ) were evaluated against four cancer cells (Hep-2, HepG2, MCF-7, A375) and the normal Vero cell. Significant anti-cancer activities were observed and compared with the standard drug Doxorubicin. In vitro experimental results revealed that compound 12b is a promising lead with IC 50 values of 11 μM, 13 μM, 11 μM, 11 μM, and 91 μM against Hep-2, HepG2, MCF-7, A375, and Vero, respectively. Herein, we present the iodine catalyzed an efficient synthesis of imidazo[1,2- a ]pyrazine and pyridine derivatives and studied their anticancer activities against in vitro cancer cell lines namely, Hep-2, HepG2, MCF-7, and A375.